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In order to overcome inconsistencies in the reporting of outcomes in clinical tri-
als, core outcome sets (COSs) have been developed in many clinical areas and
the awareness of this concept is growing steadily. The Outcomes for Pressure
Ulcer Trials (OUTPUTs) project aims to improve the quality of evidence from
pressure ulcer prevention trials by developing a COS. As an initial step in the
COS process we aimed to identify and classify both outcomes and concepts that
represent potential outcomes for future trials that have been reported in pressure
ulcer prevention research. A review was conducted in 12 major databases cover-
ing the literature indexed until 2016. Outcomes and relevant concepts reported
in primary studies and/or reviews on pressure ulcer prevention in adult patients
were extracted as presented in the articles, and afterwards inductively grouped
into outcome domains. The domains were then categorized according to the out-
come domain taxonomy recently proposed by the COMET group. In total 332
studies were included and 68 outcome domains were identified, covering multi-
ple aspects of pressure ulcer prevention. Pressure ulcer occurrence was reported
in 71% of all included studies, representing the most frequent outcome, followed
by costs (22% of all studies) and acceptability of intervention and comfort (18%
of all studies). A plethora of different outcomes are applied in pressure ulcer pre-
vention research and substantial variations in definitions and reporting of similar
outcomes were observed. A COS for pressure ulcer prevention trials is needed to
overcome the noncomparability of outcomes.
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A pressure ulcer is defined as ‘localized damage to the skin
and/or underlying tissue, as a result of pressure or pressure in
combination with shear’. Patients whose ability to move or
position themselves is impaired are especially vulnerable to
the development of pressure ulcers due to prolonged tissue
exposure to pressure. Pressure ulcer prevention comprises dif-
ferent strategies (Figure 1).
Interventions aim to reduce the magnitude and duration of
mechanical load such as pressure or shear forces, or intend to
enhance tissue tolerance, for example by application of skin-
care products.1,2 Important efforts to establish and improve
pressure ulcer prevention have been made in the past. Overall,
the availability and quality of evidence to make recommenda-
tions for pressure ulcer prevention are weak.3 Thus, further
research is necessary.4–6
There are many clinical trials testing pressure ulcer preven-
tion strategies. Unfortunately, there is also huge heterogeneity
and inconsistency of outcomes used in pressure ulcer preven-
tion trials. Outcomes are dependent variables measured during
interventional studies and enable researchers to make state-
ments about the effects, effectiveness and/or safety of inter-
ventions.7 The selection of patient-relevant and valid outcomes
in clinical trials is crucial for the quality of study results.8,9 In
order to generate meaningful evidence, it is also important
that the study results of the same clinical area are comparable,
as otherwise they cannot be summarized and pooled in sys-
tematic reviews or meta-analyses.10
The incomparability of outcomes restricts evidence-based
knowledge and aggravates decision making for clinicians in
practice. To improve this situation, the concept of ‘core out-
come sets’ (COSs) has been introduced and is promoted in
many clinical areas now. A COS represents an agreed standard-
ized set of outcomes that should be reported as a minimum in
all clinical trials of a specific area (www.comet-initiative.
org).11 Developing a COS is a multistep consensus process that
defines what to measure (core outcome domain set) and the
measurement methods to quantify the determined core out-
comes (core outcome measurement set). To date, no COS for
pressure ulcer prevention trials exists. Thus, the ‘Outcomes for
Pressure Ulcer Trials project’ (OUTPUTs project) has set the
objective to develop a COS for this field following the latest
methodological standards and recommendations.12–14 The aim
is to develop a COS for the evaluation of the clinical efficacy,
effectiveness and safety of pressure ulcer prevention strategies.
According to the Harmonising Outcome Measures for
Eczema (HOME) roadmap,15 a suggested starting point for
developing a COS is a list of all outcome domains (‘long
list’).11 Within this review, outcomes and outcome domains
are regarded as synonyms because both are intended to mea-
sure the ‘what’ of outcomes. However, differences exist of
Figure 1 Conceptual scheme of pressure ulcer prevention.
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how broadly or abstractly the outcome domains are defined.16
The aim of this research was to compile as comprehensive a
list of outcome domains for clinical trials as possible. We
sought to identify and classify both outcomes and concepts
that represent potential outcomes for future trials that have
been used and/or described in previous pressure ulcer preven-
tion research literature.
Methods
A protocol describing the steps of the OUTPUTs project to
develop a COS has been published.17 The OUTPUTs project is
registered in the COMET database (http://www.comet-initia
tive.org/studies/details/283) and is part of the Cochrane Skin
Core Outcome Set Initiative (http://cs-cousin.org/outputs).
As one first step of this project, a scoping review was con-
ducted to identify as many potential outcomes for pressure
ulcer prevention trials as possible, including patient-reported
outcomes (PROs), which are defined as outcomes that are
directly reported by patients. Compared with a systematic
review, a scoping review has less depth, but is favourable to
get an overview of a broad topic and can cover a broader con-
ceptual range.18,19 Unlike a systematic review this review did
not aim to assess the ‘weight’ of evidence or appraise the
methodological quality of studies, but aimed to provide a
comprehensive overview of outcome domains.19–21
Search strategy
Systematic searches were conducted between February and
August 2016 in the following electronic databases: Cochrane
Wounds Group/Cochrane Skin Group/Cochrane Wounds
Group Specialised Register, Cochrane Central Register of Con-
trolled Trials, Ovid MEDLINE, Ovid Embase, EBSCO CINAHL,
PsychINFO, British Nursing Index, Allied and Complementary
Medicine Database, Web of Knowledge, Clinical trials.gov and
the WHO International Clinical Trials Registry Platform Search
Portal. Database-specific search strategies were used covering
the concept of ‘pressure ulcer’ (example in Appendix S1; see
Supporting Information). The search strategies comprised con-
trolled terms and free-text words retrieved from existing sys-
tematic reviews on pressure ulcer prevention efficacy.22–29
Electronic searches for evidence on PROs regarding pressure
ulcer prevention were based for the most part on the same
search strings used by Gorecki et al.30 An update of the
searches was not planned because it can be assumed that out-
come saturation is reached using our comprehensive search
strategy.
Eligibility criteria
The COMET Handbook recommends that the scope of a
review ‘should be carefully considered in the context of the
COS to ensure that outcomes are included from all relevant
studies without unnecessary data collection’.11 It emphasizes,
as does the Cochrane Skin Core Outcome Set Initiative, that
not only clinical trials but also other study types like qualita-
tive work should be considered.11,14 Therefore, even though
our future COS should be applicable only for clinical trials on
pressure ulcer prevention, other study types were also eligible
for inclusion as they could contribute additional outcomes.
In this review, controlled trials and systematic reviews
investigating the efficacy, effectiveness and/or safety of pres-
sure ulcer prevention interventions, full health economic eval-
uations and any kind of primary studies and systematic
reviews exploring PROs related to pressure ulcers or pressure
ulcer prevention were eligible. If a publication such as a posi-
tion paper appeared to the reviewer as relevant for the identi-
fication of pressure ulcer prevention outcomes, this criterion
took precedence over the exclusion criteria regarding the study
design and it was included as well. Due to the objective of
this review the eligibility assessment process was therefore
carried out in an inclusive rather than exclusive way.
For feasibility reasons, papers had to be published in the
English language. No restrictions were set in terms of health-
care settings or publication date, except for the primary stud-
ies on PROs, which were only taken into account when they
were published after 2008, as a systematic review by Gorecki
et al. in 2009 on PROs related to pressure ulcer and other
chronic wounds already existed.30 Studies with a target popu-
lation aged < 18 years and that included healthy volunteers
only were excluded. A detailed list of the inclusion and exclu-
sion criteria is shown in Appendix S2 (see Supporting Infor-
mation).
Study selection
All identified publications were imported to the Covidence
platform (www.covidence.org), which was used for the study
selection procedures. After removal of duplicates, the refer-
ences were assessed for eligibility based on title and abstract
screening, followed by full-text screening. The evaluation was
performed independently by pairs of two reviewers of the
project team. Discrepancies were discussed within the project
team in order to reach a final decision.
Data charting and synthesis
Data on key study characteristics (author, year, country, study
type, type of intervention, healthcare setting and target popu-
lation) and both outcomes and concepts that present potential
outcomes for clinical trials were extracted into standardized
data files by means of SPSS 23 (IBM, Armonk, NY, USA). The
data extraction was performed by two reviewers indepen-
dently and cross-checked by a third reviewer. Cases of dis-
agreement were resolved among the data extractors through
discussion. The concepts of outcomes were extracted as pre-
sented in the studies. Based on an inductive approach, the
identified potential outcomes of the literature were compiled
to overarching outcome domains by two project members in
cooperation and were reviewed by the whole project team.
Identified outcome domains were then assigned to broader
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outcome domains and core areas according to the taxonomy
of Dodd et al.31
This newly developed taxonomy of Dodd et al. comprises
38 overall domains, allocated to the five core areas ‘death’,
‘physiological/clinical’, ‘life impact’, ‘resource use’ and ‘ad-
verse events’. Tools measuring health-related quality of life,
which comprised several questions and therefore covered mul-
tiple outcome domains, were classified within each of the sep-
arate domains, as recommended by COMET and Dodd
et al.31,32 Outcomes were only allocated to ‘global quality of
life’ when patients were generally asked to assess their quality
of life. Specifically reported adverse events were classified




The searches identified 4498 references. After removal of
duplicates and title and abstract screening, 668 full-text publi-
cations were evaluated for eligibility. Finally, 357 publications
were included for data extraction (Figure 2).
Included publications
The included publications comprised 51 reviews and 281 pri-
mary studies. Twenty-five publications were identified as addi-
tional articles on a study already included. Most of the
included studies were randomized controlled trials or con-
trolled trials (n = 190). The other primary studies were
identified as qualitative studies (n = 24) or full health eco-
nomic evaluations (n = 21) or were allocated to the category
‘other’ (n = 46). The category ‘other’ comprised among others
pre- and postimplementation studies, a series of single-case
studies, a quasiexperimental study with interrupted time-series
design and case–control studies. These studies were included
as the reviewers assessed these publications as beneficial in the
identification of pressure ulcer prevention outcomes, which
took precedence over the study design.
Identified outcomes
Based on all identified outcomes in the included studies, 68
outcome domains were inductively created (Table 1). A
detailed description of the extracted terms per outcome is
shown in Appendix S3 (see Supporting Information). Most of
the identified outcomes belonged to the outcome domain
‘skin and subcutaneous tissue outcomes’ according to Dodd
et al.31 To this broad outcome domain of Dodd et al. we have
allocated 21 outcome domains such as ‘tissue oxygenation’,
‘skin temperature’ or ‘pressure ulcer occurrence’. Pressure
ulcer occurrence referring to the whole body (no. 18) was
reported in 168 studies (95 clinical trials, 36 other primary
studies and 37 reviews) and pressure ulcer occurrence refer-
ring to distinct body sites (no. 19) in 64 studies (51 clinical
trials, seven other primary studies and six reviews). Therefore,
pressure ulcer occurrence was the most frequently captured
outcome overall. There was a great variety in the terminology
and reporting of pressure ulcer (Appendix S3, no.18).
When reporting the frequency of pressure ulcer occurrence
the included references stated among other measures the
Figure 2 Flowchart of the screening and eligibility assessment process. CT, controlled trial; PRO, patient-reported outcome; PU, pressure ulcer;
RCT, randomized controlled trial.
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incidence or the prevalence of pressure ulcers, hospital-ac-
quired pressure ulcer prevalence, the raw numbers of pressure
ulcers that occurred, or the time until occurrence. There were
also differences in the reported categories (e.g. including or
excluding category 1, only category 3 and above). Some pub-
lications assessed the whole body, whereas others defined
specific body areas for the assessment of pressure ulcer occur-
rence. Examples of the verbatim text describing the body areas
that were considered for evaluation are ‘sacrum, hips and
heels’, ‘sacrum, buttocks and heels’, ‘trunk and heels’ and
‘trochanter’ (Appendix S3, no. 19).
The second most commonly reported outcome domain was
‘costs’, including cost outcomes that were associated with a
prevention intervention in any manner, like cost savings per
year, hospital costs or direct staff costs (Appendix S3, no. 64).
Cost outcomes were reported in 73 studies. ‘Acceptability of
intervention and comfort’ was another frequent outcome
domain (reported in 59 studies, no. 59). This domain repre-
sents outcomes that were reported by patients.33 Other exam-
ples of listed PROs are ‘pain associated with pressure ulcer’
(no. 35), ‘pain associated with intervention’ (no. 36), ‘emo-
tional wellbeing’ (no. 53), ‘patient satisfaction with interven-
tion’ (no. 58) and ‘global quality of life’ (no. 56).
In order to evaluate the success of a pressure ulcer preven-
tion intervention, trials also assessed outcomes that were con-
sidered to correlate with the development of pressure ulcer
occurrence, like ‘interface pressure’ (no. 22), ‘blood perfu-
sion’ (no. 23), ‘skin function’ (no. 31) or ‘tissue oxygena-
tion’ (no. 24). Domains like ‘nutritional intake’ (no. 15) and
‘nutritional status’ (no. 14) are examples of intervention-
specific domains, which are relevant only for trials investigat-
ing nutritional supplementation.
Types of preventive interventions
Table 2 shows the most frequent types of preventive interven-
tions used in the included studies. The effects of support sur-
faces for the bed were reported most frequently (n = 93),
followed by trials that evaluated the implementation of any
kind of preventive guidelines or programmes, like the
implementation of educational programmes or bundle-of-care
interventions (n = 47). Other interventions that were also
common (reported in more than 20 studies) are the applica-
tion of preventive dressings and repositioning.
Discussion
As described in previous systematic reviews,4,25,26 the report-
ing of pressure ulcer occurrence was heterogeneous. There
were differences not only in how the occurrence of pressure
ulcers was reported, but also regarding the body sites. Even
when similar body areas were evaluated for the effectiveness
of pressure ulcer prevention, a great variation of definitions
exists (e.g. sacrum, buttocks, trochanter, trunk, pelvis). The
use of the same terminology, classification systems and
method to calculate pressure ulcer occurrence is important to
enhance the comparison of study results.34 The harmonization
of capturing and reporting the identified core outcome
domains will be a major task in future project steps, when it
comes to developing the measurement methods.
Besides the occurrence of pressure ulcers, many other out-
comes showed huge variation as well. For example, the indi-
rect measure ‘interface pressure’ included, among others, the
outcomes ‘maximum interface pressure’, ‘mean interface pres-
sure’ and ‘the average of highest four pressures’. Regarding
‘blood perfusion’ some studies measured the ‘skin perfusion’
and others the ‘capillary blood flow’ or ‘tissue blood flow’.
These examples emphasize again the difficulties that can
emerge when trying to pool study results.
Our review results also indicate that there is heterogeneity
between outcomes regarded as important in reviews and in
primary studies. For example, ‘sleep’ was reported in primary
studies, but not in any of the included reviews. On the other
hand, some outcomes reported in the reviews were not
applied in primary studies. This situation is similar in other
fields. For example, a recently published review showed that
68% of dermatological trial outcomes were not included as
outcomes in the corresponding Cochrane Reviews, and vice
versa, 28% of outcomes defined by the reviewers were not
reported in any supporting trial.35 Similar observations have
Table 2 Types of preventive interventions reported in the included studies







Support surface – bed 66 20 7
Guideline, education, programmes 23 14 10
Dressings 23 2 3
Repositioning 13 4 4
Support surface – sitting position 14 3 2
Nutrition 6 4 3
Heel offloading 6 1 3
Any intervention or pressure ulcer prevention in general 0 2 4
Mobility promotion 0 1 0
Other 39 40 15
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been made in the fields of oncology36 and preterm birth pre-
vention.37 This indicates that trialists and systematic reviewers
differ in their opinions regarding relevant outcomes, which
has the potential to result in research waste.38 Therefore both
trialists and systematic reviewers should participate as key
stakeholders in the subsequent COS consensus process.
Some of the extracted outcomes seem more appropriate for
trials of treatment rather than prevention interventions. For
example, the outcomes ‘pain associated with pressure ulcer’
and ‘pressure ulcer status’ may appear unsuitable regarding
pressure ulcer prevention, as they commonly appear in con-
nection with ulcer treatment. However, these outcomes also
fit into the concept of tertiary prevention, which describes the
prevention of deterioration. This is why these outcomes were
also extracted when reported in pressure ulcer prevention
studies. The possible overlap between prevention and treat-
ment outcomes was observed in other COS initiatives as
well.39–41 Therefore, one of the next steps is to further define
the concept and levels of pressure ulcer prevention to be used
in OUTPUTs. Furthermore, many intervention-specific out-
comes were identified, such as ‘weight gain’ or ‘nutritional
status’. It must be decided whether it is more useful to
develop an intervention-specific COS or a generic COS that is
applicable for all types of interventions. In the latter case,
intervention-specific outcomes are to be excluded.
This review included not only clinical trials and reviews,
but also other study designs. The inclusion of qualitative stud-
ies is considered especially important, because they are a rele-
vant source in identifying potential outcomes important for
patients.42 Including other evidence sources in addition to
published clinical trials increases the review and data extrac-
tion workload, but in this review it allowed us to identify the
following eight outcome domains that would otherwise have
been missed: ‘appetite’, ‘patient’s balance’, ‘injuries reported
as adverse event’, ‘disorientation/confusion reported as
adverse event’, ‘muscle tonus’, ‘self-consciousness and self-es-
teem’, ‘privacy’ and ‘time investment by patient’. Finding an
optimal balance between more sensitive or more specific liter-
ature searches for long-list creation in COS development is
challenging, but we support the statement that looking at pub-
lished clinical trials only is insufficient.14,42
The results of this review provide the basis for the next
steps of the OUTPUTs initiative, whose main objective is to
reduce this long list down to a consensus agreed list of essen-
tial outcome domains. Although the project group follows the
latest methodological guidance, there are a number of
methodological challenges in this new field, such as how best
to involve patients in the development of a COS without over-
straining them. Involving patients as participants in an e-Del-
phi survey might be difficult due to the complex question,
which needs a deeper understanding of the concept of a COS.
To ensure meaningful involvement of patients, it is essential
to provide assistance and guidance. In addition, it is crucial
that all outcome domains are presented with clear definitions,
so that all participants understand their meaning and are able
to rate their importance. Further, it is also not yet settled how
to address the issue of timing.14,43 Variations in time periods
over which studies are conducted are challenging regarding
the interpretation of trial results.34 Timing is therefore also a
factor that might be considered in sorting out the heterogene-
ity of trial results. Whatever form this may take, it will proba-
bly be necessary to distinguish between timing in terms of
indirect outcomes of pressure (e.g. blood perfusion, tissue
oxygenation, interface pressure) and direct outcomes of pre-
vention (pressure ulcer development regarding the whole
body, regarding defined body sites or being device related).
Limitations of the study are as follows. Only papers in the
English language were included in this review, which may be
regarded as language bias. Although the literature search was
conducted in the most relevant electronic databases, there
might be publications that were not identified. Qualitative
studies were included to capture the views of patients and ser-
vice users. Nevertheless, additional ways are needed to identify
possibly missing outcomes, such as direct interviews with
patients. The review was completed in 2016. Because data sat-
uration was reached, it is unlikely that new outcomes have
been introduced in the literature since then.
In conclusion, pressure ulcer occurrence is the most com-
monly reported outcome in pressure ulcer prevention
research, but there is also a wide range of other outcomes. So
far, there has not been a harmonization regarding the rele-
vance of the single outcomes. OUTPUTs will help to prioritize
and standardize the outcome selection in future pressure ulcer
prevention trials.
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